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MicroRNAs (miRNAs) are short ribonucleic acid molecules that regulate the expression of a gene 
after it has been transcribed into messenger RNA (mRNA). This form of post-transcriptional 
regulation is accomplished when miRNA binds to complementary sequence on its target mRNA. 
Depending on the miRNA and target, the effect is usually repression of translation or mRNA 
degradation, yet positive regulation may also be possible. The human genome encodes more than 
1,000 miRNAs targeting at least half of all genes, and miRNAs appear to be involved in myriad 
biological processes. Their abnormal expression has been implicated in a number of diseases, and 
some miRNA-based cancer therapies are already under investigation. In addition to the large 
number of canonical miRNAs, addition of one or a few nucleotides to the 3’ end of any given miRNA 
may modify its stability and activity. In humans, such nucleotide additions are thought to be primarily 
accomplished by just three nucleotidyl transferases (PAPD4, PAPD5 and ZCCHC11). Widespread 
occurrence of variable 3’ nucleotide additions to miRNAs has been observed in high-throughput 
sequencing datasets. However, the degree to which this sort of miRNA diversity is biologically 
meaningful, or simply the result of artifacts during transcriptome sequencing, has remained 
uncertain. 
Significant new glimpses into the depth and biological importance of 3’ miRNA nucleotide additions 
have been made in a paper published by co-leading authors Stacia Wyman and Emily Knouf 
(Human Biology Division), senior author Muneesh Tewari (Human Biology Division) and three other 
researchers affiliated with Fred Hutchinson Cancer Research Center (Rachael Parkin, Daniel Lin 
and Brian Fritz). Contributions were also made by collaborators at Seattle’s NanoString 
Technologies. In carefully controlled sequencing experiments, Wyman, Knouf and colleagues 
demonstrated that 3’ nucleotide additions occur physiologically (and often) in normal tissue. The 
research team then adapted NanoString Technologies’ nCounter assay for the high-throughput 
quantification of 3’ miRNA variants. Using their new approach, Wyman et al. detected miRNA 
variants that changed dynamically during the differentiation of human embryonic stem cells,  
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exemplifying that 3’ miRNA variation is biologically regulated. Lastly, the researchers used RNA 
interference to individually suppress eight candidate nucleotidyl transferases in colon-cancer cell 
culture, again employing their adapted protocol to monitor 3’ miRNA variants. Seven enzymes 
affected 3’ variation, three of which (MTPAP, ZCCHC6 and TUT1) were not known previously to 
modify miRNAs. This impressive body of work illustrates that 3’ nucleotide addition is a much more 
common and biologically meaningful mechanism of generating miRNA transcriptome complexity 
than previously recognized. The authors’ findings will likely motivate new research into this facet of 
post-transcriptional gene regulation. Their identification of a greater diversity of relevant nucleotidyl 
transferases may also contribute to future miRNA-based cancer therapies. 
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